Marizev tablets 12.5mg (YJ_code: 3969025F1022, standard: 12.5 mg 1 tablet) from Kissei Pharmaceutical contains omarigliptin, a once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor approved in Japan for type 2 diabetes. It works by inhibiting the DPP-4 enzyme, increasing incretin hormone levels to enhance insulin secretion and reduce glucagon release.
Marizev tablets 12.5mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
